{"url_path":"/fda/drug/recalls/D-0507-2026","section_key":"summary","section_title":"DRUG Recall: Wells Pharma of Houston LLC — Ketamine Hydrochloride Injectable Solution, 50mg/ml, (50 mg per mL) Volume: 1 mL, 5265 Kitty Drive, Houston, TX  77054, NDC 73702-302-31.","topic":"fda","document":{"doc_type":"drug-recall","doc_date":"2026-04-01","source_url":"https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0507-2026%22","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Wells Pharma of Houston LLC"},"word_count":87,"has_tables":false,"body_markdown":"# FDA DRUG Recall: D-0507-2026\n\n**Recalling firm:** Wells Pharma of Houston LLC\n**Classification:** Class II\n**Status:** Ongoing\n**Type:** Voluntary: Firm initiated\n**Initiated:** 2026-04-01\n**Report date:** 2026-05-06\n\n## Product\nKetamine Hydrochloride Injectable Solution, 50mg/ml, (50 mg per mL) Volume: 1 mL, 5265 Kitty Drive, Houston, TX  77054, NDC 73702-302-31.\n\n## Reason\ncGMP deviations.\n\n## Affected lots\n120925302312764, Exp Date 04/09/2026, 123125302312879  Exp Date, 05/05/2026, 123125302312880, Exp Date 05/05/2026, 010226302310003, Exp Date 05/06/2026, 010626302310007, Exp Date 05/08/2026, 010626302310008, Exp Date 05/08/2026  020426302310243, Exp Date 06/06/2026.\n\n## Distribution\nU.S. Nationwide."}